Enhanced dopamine release and phosphorylation of synapsin I and neuromodulin in striatal synaptosomes after repeated amphetamine

Journal of Pharmacology and Experimental Therapeutics

Volumn 283, Issue 3, 1997, Pages 1445-1452

  Iwata, Shin Ichi ^a,b   Hewlett, G H Keikilani ^a   Ferrell, Sandra T ^a   Kantor, Lana ^a   Gnegy, Margaret E ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; DOPAMINE; NEUROMODULIN; PROTEIN KINASE C; SYNAPSIN I;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; DOPAMINE RELEASE; ENZYME ASSAY; FEMALE; NONHUMAN; PRIORITY JOURNAL; RAT; STOICHIOMETRY; SYNAPTOSOME;

AMPHETAMINE; ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM; CORPUS STRIATUM; DOPAMINE; FEMALE; GAP-43 PROTEIN; PHOSPHORYLATION; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; SYNAPSINS; SYNAPTOSOMES;

EID: 0031443572     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. ALEXANDER, K. A., CIMLER, B. M., MEIER, K. E. AND STORM, D. R.: Regulation of calmodulin-binding to P-57. J. Biol. Chem. 262: 6108-6113, 1987.
2. 2+/calmodulin-dependent protein kinase II is a binding protein for synapsin I. Nature 359: 417-420, 1992.
3. CASTAÑEDA, E., BECKER, J. B. AND ROBINSON, T. E.: The long-term effects of repeated amphetamine treatment in vivo on amphetamine, KCl and electrical stimulation evoked striatal dopamine release in vitro. Life Sci. 42: 2447-2456, 1988.
4. COGGINS, P. J. AND ZWIERS, H.: B-50 (GAP-43): Biochemistry and functional neurochemistry of a neuron-specific phosphoprotein. J. Neurochem. 56: 1095-1106, 1991.
5. CZERNIK, A. J., MATHERS, J., TSOU, K., GREENGARD, P. AND MISCHE, S. M.: Phosphorylation state-specific antibodies: Preparation and applications. Neuroprotocols 6: 56-61, 1995.
6. DAVIS, J. M. AND SCHLEMMER, R. F.: The amphetamine psychosis. In Amphetamines and Related Stimulants, ed. by J. Caldwell, pp. 161-173, CRC Press, Boca Raton, FL, 1980.
7. 2+-dependent regulator protein of cyclic nucleotide phosphodiesterase: Relationship of Ca2+ binding, conformational changes, and phosphodiesterase activity. J. Biol. Chem. 252: 8415-8422, 1977.
8. DEKKER, L. V., DE GRAAN, P. N., OBSTREICHER, A. B., VERSTEEG, D. H. G. AND GISPEN, W. H.: Inhibition of noradrenaline release by antibodies to B-50 (GAP-43). Nature 342: 74-76, 1989a.
9. 3H]noradrenaline release in rat brain synaptosomes. Eur. J. Pharmacol. 188: 113-122, 1990.
10. DEKKER, L. V., DE GRAAN, P. N. E., VERSTEEG, D. H. G., OBSTREICHER, A. B. AND GISPEN, W. H.: Phosphorylation of B-50 (GAP43) is correlated with neurotransmitter release in rat hippocampal slices. J. Neurochem. 52: 24-30, 1989b.
11. DUNKLEY, P. R., HEATH, J. W., HARRISON, S. M., JARVIE, P. E., GLENFIELD, P. J. AND ROSTAS, J. A. P.: A rapid Percoll gradient procedure for isolation of synaptosomes directly from an S1 fraction: Homogeneity and morphology of subcellular fractions. Brain Res. 441: 59-71, 1988a.
12. DUNKLEY, P. R., JARVIE, P. E. AND ROSTAS, J. A. P.: Distribution of calmodulin-and cyclic AMP-stimulated protein kinases in synaptosomes. J. Neurochem. 51: 57-68, 1988b.
13. FISCHER, J. F. AND CHO, A. K.: Chemical release of dopamine from striatal homogenates: Evidence for an exchange diffusion model. J. Pharmacol. Exp. Ther. 208: 203-209, 1979.
14. FLOOR, E. AND MENG, L.: Amphetamine releases dopamine from synaptic vesicles by dual mechanisms. Neurosci. Lett. 215: 53-56, 1996.
15. 2+/calmodulin-dependent protein kinase II and its endogenous substrates in the induction of long term potentiation. J. Biol. Chem. 270: 6119-6124, 1995.
16. GIAMBALVO, C. T.: Protein kinase C and dopamine transport-2: Effects of amphetamine in vitro. Neuropharmacology 31: 1211-1222, 1992.
17. GNEGY, M. E., HEWLETT, G. H. K., YEE, S. L. AND WELSH, M. J.: Alterations in calmodulin content and localization in areas of rat brain after repeated intermittent amphetamine. Brain Res. 562: 6-12, 1991.
18. GNEGY, M. E., HONG, P. AND FERRELL, S. T.: Phosphorylation of neuromodulin in rat striatum after acute and repeated, intermittent amphetamine. Brain Res. 20: 289-298, 1993.
19. GREENGARD, P., VALTORTA, F., CZERNIK, A. J. AND BENFENATI, F.: Synaptic vesicle phosphoproteins and regulation of synaptic function. Science 259: 780-785, 1993.
20. HAN, Y., WANG, W., SCHLENDER, K. K., GANJEIZADEH, M. AND DOKAS, L. A.: Protein phosphatases 1 and 2A dephosphorylate B-50 in presynaptic plasma membranes from rat brain. J. Neurochem. 59: 364-374, 1992.
21. 2+/calmodulin-dependent protein kinase and mutational analysis of its autoregulation. Neuron 3: 59-70, 1989.
22. 2+-dependent interaction of calmodulin with the head domain of synapsin 1. Biochem. J. 275: 93-97, 1991.
23. HEFFNER, T. G., HARTMAN, J. A. AND SEIDEN, L. S.: A rapid method for the regional dissection of the rat brain. Pharmacol. Biochem. Behav. 13: 453-456, 1980.
24. 2+-induced noradrenaline release, B-50 phosphorylation and dephosphorylation, and calmodulin binding. J. Neurochem. 64: 1127-1136, 1995.
25. 2+ trigger. J. Neurochem. 60: 1264-1273, 1993.
26. HENS, J. J. H., OBSTREICHER, A. B., DE WIT, M., MARQUART, A., GISPEN, W. H. AND D. E. GRAAN, P. N. E.: Evidence for a role of calmodulin in calcium-induced noradrenaline release from permeated synaptosomes: Effects of calmodulin antibodies and antagonists. J. Neurochem. 66: 1933-1942, 1996.
27. IVINS, K. J., NEVE, K. A., FELLER, D. J., FIDEL, S. A. AND NEVE, R. L.: Antisense GAP-43 inhibits the evoked release of dopamine from PC 12 cells. J. Neurochem. 60: 626-633, 1993.
28. IWATA, S., HEWLETT, G. H. K., FERRELL, S. T., CZERNIK, A. J., MEIRI, K. F. AND GNEGY, M. E.: Increased in vivo phosphorylation of neuromodulin and synapsin I in striatum from rats treated with repeated amphetamine. J. Pharmacol. Exp. Ther. 278: 1428-1434, 1996.
29. IWATA, S., HEWLETT, G. H. K. AND GNEGY, M. E.: Amphetamine increases the phosphorylation of neuromodulin and synapsin I in rat striatal synaptosomes. Synapse 26: 281-291, 1997.
30. KOLTA, M. G., SHREVE, P., D. E. SOUZA, V. AND URETSKY, N. J.: Time course of the development of the enhanced behavioral and biochemical responses to amphetamine after pretreatment with amphetamine. Neuropharmacology. 24: 823-829, 1985.
31. KRAMER, J. C., FISCHMAN, V. S. AND LITTLEFIELD, D. C.: Amphetamine abuse. J. A. M. A. 201: 89-93, 1967.
32. LIU, Y. AND STORM, D. R.: Dephosphorylation of neuromodulin by calcineurin. J. Biol. Chem. 264: 12800-12804, 1989.
33. LLINAS, R., GRUNER, J. A., SUGIMORI, M., MCGUINNESS, T. L. AND GREENGARD, P.: Regulation by synapsin I and Ca(2+)-calmodulin-dependent protein kinase II of the transmitter release in squid giant synapse. J. Physiol. (Lond.) 436: 257-282, 1991.
34. MEIRI, K. F., BICKERSTAFF, L. E. AND SCHWOB, J. E.: Monoclonal antibodies show that kinase C phosphorylation of GAP-43 during axonogenesis is both spatially and temporally restricted in vivo. J. Cell Biol. 112: 991-1005, 1991.
35. NICHOLS, R. A., CHILCOTE, T. J., CZERNIK, A. J. AND GREENGARD, P.: Synapsin I regulates glutamate release from rat brain synaptosomes. J. Neurochem. 58: 783-785, 1992.
36. PAULSON, P. E., CAMP, D. M. AND ROBINSON, T. E.: Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats. Psychopharmacology 103: 480-492, 1991.
37. PAULSON, P. E. AND ROBINSON, T. E.: Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: A microdialysis study in behaving rats. Synapse 19: 56-65, 1995.
38. PIERCE, R. C. AND KALIVAS, P. W.: Repeated cocaine modifies the mechanism by which amphetamine releases dopamine. J. Neurosci. 17: 3254-3261, 1997.
39. PIERIBONE, V. A., SHUPLIAKOV, O., BRODIN, L., HILFIKER-ROTHENFLUH, S., CZERNIK, A. J. AND GREENGARD, P.: Distinct pools of synaptic vesicles in neurotransmitter release. Nature 375: 493-497, 1995.
40. ROBERTS-LEWIS, J. M., WELSH, M. J. AND GNEGY, M. E.: Chronic amphetamine treatment increases striatal calmodulin in rats. Brain Res. 384: 383-386, 1986.
41. ROBINSON, T. E.: The neurobiology of amphetamine psychosis: Evidence from studies with an animal model. In Taniguchi Symposia on Brain Sciences, Vol. 14: Biological Basis of Schizophrenic Disorders, ed. by T. Nakazawa, pp. 185-201, Japan Scientific Societies Press, Tokyo, 1991.
42. ROBINSON, T. E. AND BECKER, J. B.: Behavioral sensitization is accompanied by an enhancement in amphetamine-stimulated dopamine release from striatal tissue in vitro. Eur. J. Pharmacol. 85: 253-254, 1982.
43. ROBINSON, T. E. AND BECKER, J. B.: Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev. 11: 157-198, 1986.
44. ROBINSON, T. E. AND CAMP, D. M.: Long-lasting effects of escalating doses of d-amphetamine on brain monoamines, amphetamine-induced stereotyped behavior and spontaneous nocturnal locomotion. Pharmacol. Biochem. Behav. 26: 821-827, 1987.
45. ROSAHL, T. W., SPILLANE, D., MISSLER, M., HEKZ, J., SELIG, D. K., WOLFF, J. R., HAMMER, R. E., MALENKA, R. C. AND SUDHOF, T. C.: Essential functions of synapsins I and II in synaptic vesicle regulation. Nature 375: 488-493, 1995.
46. SATO, M.: Acute exacerbation of methamphetamine psychosis and lasting dopaminergic supersensitivity: A clinical survey. Psychopharmacol. Bull. 22: 751-756, 1986.
47. SEGAL, D. S. AND KUCZENSKI, R.: Behavioral pharmacology of amphetamine. In Amphetamine and Its Analogs, ed. by A. K. Cho and D. S. Segal, pp. 115-150, Academic Press, San Diego, CA, 1994.
48. SEIDEN, L. S., SABOL, K. E. AND RICAURTE, G. A.: Amphetamine: Effects on catecholamine systems and behavior. Annu. Rev. Pharmacol. Toxicol. 33: 639-677, 1993.
49. SHEARMAN, M. S., SHINOMURA, T., ODA, T. AND NISHIZUKA, Y.: Protein kinase C subspecies in adult rat hippocampal synaptosomes: Activation by diacylglycerol and arachidonic acid. FEBS. Lett. 279: 261-264, 1991.
50. SKENE, J. H. P.: Axonal growth-associated proteins. Ann. Revu. Neurosci. 12: 127-156, 1989.
51. TANAKA, C. AND SAITO, N.: Localization of subspecies of protein kinase C in the mammalian central nervous system. Neurochem. Int. 21: 499-512, 1992.
52. 3H]dopamine uptake in rat striatum: Possible involvement of calmodulin-dependent kinases. J. Neurochem. 65: 2065-2071, 1995.
53. VALTORTA, F., BENFENATI, F. AND GREENGARD, P.: Structure and function of the synapsins. J. Biol. Chem. 267: 7195-7198, 1992.
54. VEZINA, P.: Amphetamine injected into the ventral tegmental area sensitizes the nucleus accumbens dopaminergic response to systemic amphetamine: An in vivo microdialysis study in the rat. Brain Res. 605: 332-337, 1993.
55. WALAAS, S. I., JAHN, R. AND GREENGARD, P.: Quantitation of nerve terminal populations: Synaptic vesicle-associated proteins as markers for synaptic density in the rat neostriatum. Synapse 2: 516-520, 1988.
56. WOLF, M. E., WHITE, F. J., NASSAR, R., BROODERSON, R. J. AND KHANSA, M. R.: Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J. Pharmacol. Exp. Ther. 264: 249-255, 1993.
57. YAMADA, S., KOJIMA, H., YOKOO, H., TSUTSUMI, T., TAKAMUKI, K., ANRAKU, S., NISHI, S. AND INANAGA, K.: Enhancement of dopamine release from striatal slices of rats that were subchronically treated with metamphetamine. Biol. Psychiatr. 24: 399-408, 1988.
58. YASUDA, I., KISHIMOTO, A., TANAKA, S., TOMINAGA, M., SAKURAI, A. AND NISHIZUKA, Y.: A synthetic peptide substrate for selective assay of protein kinase C. Biochem. Biophys. Res. Commun. 166: 1220-1227, 1990.
59. YOSHIHARA, C., SAITO, N., TANIYAMA, K. AND TANAKA, C.: Differential localization of four subspecies of protein kinase C in the rat striatum and substantia nigra. J. Neurosci. 11: 690-700, 1991.